Bridge Medicines

Accelerating drug discovery from academic research to human proof of concept

placeNew York City, New York, United States calendar_todayFounded 2016 groups4 employees language bridgemedicines.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 33 times.

YearFilings
20211
20222
20232
20243
20252
20261

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon